Buhl, Roland; Miravitlles, Marc; Anzueto, Antonio et al.
Long-acting muscarinic antagonist and long-acting β<sub>2</sub>-agonist combination for the treatment of maintenance therapy-naïve patients with chronic obstructive pulmonary disease: a narrative reviewTHERAPEUTIC ADVANCES IN RESPIRATORY DISEASE. Bd. 18. 2024
Fliesser, Elisabeth; Jandl, Katharina; Lins, Thomas et al.
Lung Fibrosis Is Linked to Increased Endothelial Cell Activation and Dysfunctional Vascular Barrier IntegrityAMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY. Bd. 71. H. 3. 2024 S. 318-331
Kreuter, Michael; Lee, Joyce S.; Tzouvelekis, Argyrios et al.
Modified blood cell GAP model as a prognostic biomarker in idiopathic pulmonary fibrosisERJ OPEN RESEARCH. Bd. 10. H. 4. 2024
Behr, Juergen; Bonella, Francesco; Frye, Bjoern Christian et al.
Pharmacological Treatment of Idiopathic Pulmonary Fibrosis (Update) and Progressive Pulmonary Fibroses: S2k Guideline of the German Respiratory SocietyRESPIRATION. Bd. 103. H. 12. 2024 S. 782-810
Kreuter, Michael; Schaedler, Hubert
Pneumology out of the box. Intersectoral modern diagnostics and treatmentZEITSCHRIFT FUR PNEUMOLOGIE. Bd. 21. H. 2. 2024 S. 71-72
Berger, Melanie; Zimmermann, Maximilian; Kreuter, Michael et al.
Pulmonale Beteiligung bei idiopathischen inflammatorischen MyopathienPNEUMOLOGIE. Bd. 78. H. 03. 2024 S. 167-179
Polke, M.; Polke, N.; Piel, S. et al.
Pulmonary lymphangiomatosis: insights into an ultra-rare diseaseRESPIRATORY RESEARCH. Bd. 25. H. 1. 2024
Sousa-Pinto, Bernardo; Louis, Gilles; Vieira, Rafael J. et al.
Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK-air studyCLINICAL AND TRANSLATIONAL ALLERGY. Bd. 14. H. 6. 2024
Rosendahl, Sophie; Trudzinski, Franziska C.; Polke, Markus et al.
SARS-CoV-2 Vaccination in Primary Humoral Immunodeficiency: Experience from a German Lung ClinicRESPIRATION. Bd. 104. H. 5. 2024 S. 349-359
Kreuter, M.; Distler, J.; Hechtner, M. et al.
Snapshot analysis of the INREAL study: A real-world evaluation of Nintedanib for changes in dyspnea and cough in chronic PF-ILD patientsPNEUMOLOGIE. Bd. 78. 2024 S. S85-S85